Food as medicine: Potential therapeutic tendencies of plant derived polyphenolic compounds

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 2, 2008, Pages 187-196

  Ullah, Mohd Fahad ^a   Khan, Md Wasim ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cancer; Coronary heart disease; Food; French paradox; Green tea; Polyphenols

Indexed keywords

ANTIOXIDANT; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DIET; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET; FLAVONOIDS; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHENOLS;

EID: 56749112002     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (106)

1. Adlercreutz CH, Goldin BR, Gorbach SL, et al (2003). Soybean phytoestrogen intake and cancer risk. J Nutr, 125, 757-70.
2. Adlercreutz H, Markkanen H, Watanabe S (1993). Plasma concentration of phyto-oestrogen in Japanese men. Lancet, 342, 1209-10.
3. Aggarwal BB, Bhardwaj A, Aggarwal RS, et al (2004). Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res, 24, 2783-840.
4. Alhasan S, Pietrasczkiwicz-Alonso MD, Ensley J, Sarkar FH (1999). Genistein induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer, 34, 12-9.
5. Andriambeloson E, Kleschyov AL, Muller B (1997). Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat arota. Br J Pharmacol, 20, 1053-8.
6. Azmi AS, Bhat SH, Hanif S, Hadi SM (2006). Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: Implication for a putative mechanism for anticancer properties. FEBS Lett, 580, 533-8.
7. Bagli E, Stefaniotou M, Morbidelli L (2004). Luteolin inhibits vascular endothelial growth factor induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Cancer Res, 64, 7936-46.
8. Bastianetto S, Yao ZX, Papadopoulos V, Quirion R (2006). Neuroprotective effects of green and black teas and their catechin gallate esters against betaamyloid-induced toxicity. Eur J Neurosci, 23, 55-64.
9. Batista O, Doarte A, Nascimento J, Simones MF (1994). Structure and antimicrobial activity of diterpenes from the roots of Plectranthus hereroensis. J Nat Prod, 57, 858-86.
10. Bauer V, Bauer F (1999). Reactive oxygen species as mediators of tissue protection and injury. Gen Physiol Biophys, 18, 7-14.
11. Belaia OL, Fomina IG, Baider LM, Kuropteva ZV, Tiukavkina NA (2006). The influence of the bioflavonoid dicvertin on the antioxidative system ceruloplasmin-transferrin and lipid peroxidation in patients suffering from stable coronary heart disease with dyslipidemia. Clin Med, 84, 46-50.
12. Beretz A, Anton R and Stoclet JC (1977). Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experimentia, 34, 1045-55.
13. Borris RP (1996). Natural products research: perspectives from a major pharmaceutical company. J Ethnopharmacol, 51, 29-38.
14. Bors W, Heller W, Michael M (1998). Flavonoids as antioxidants: determination of radical scavenging efficiencies. Edited by CA Rice, E Vans and L Packer, Marcel Dekker, New York.
15. Bryan SE (1979). Metal ions in biological systems. Marcel Dekker, New York.
16. Casagrande F, Darbon JM (2000). p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp Cell Res, 258, 101-8.
17. Chung SY, Sung MK, Kim NH, et al (2005). Inhibition of Pglycoprotein by natural products in human breast cancer cells. Arch Pharm Res, 28. 823-8.
18. Cowan MM (1999). Plant products as antimicrobial agents. Clin Microbiol Rev, 12, 564-82.
19. Criqui MH, Ringel BL (1994). Does diet or alcohol explain the French paradox? Lancet, 344, 1719-23.
20. Critchfield JW, Butsera ST, Folks TM (1996). Inhibition of HIV activation in latently infected cells by flavonoids compounds. AIDS Res Hum Retroviruses, 12, 39-46.
21. Critchfield JW, Coligan JE, Folks TM, Butera ST (1997). Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proc Natl Acad Sci USA, 94, 6110-5.
22. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB (2006). Fruit and vegetable juices and Alzheimer's disease: the Kame project. Am J Med, 119, 751-9.
23. Davis JN, Kucuk O, Sarkar FH (1999). Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer, 35, 167-74.
24. de Clereq (2000). Natural products for chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rep, 20, 323-49.
25. Desrosiers RC (2004). Prospects for an AIDS vaccine. Nature Med, 10, 221-3.
26. Dewick PM (1995). The biosynthesis of shikimate metabolites. Nat Prod Rep, 12, 579-607.
27. Dixon RA, Dey PM, Lamb CJ (1983). Phytoalexins: enzymology and molecular biology. Adv Enzymol, 55, 1-69.
28. Ebadi M, Swanson S (1988). The status of zinc, copper and metallothionein in cancer patients. Prog Clin Biol Res, 259, 161-75.
29. Falchi M, Bertelli A, Le Scalzo R, et al (2006). Comparison of cardioprotective abilities between the flesh and skin of grapes. J Agric Food Chem, 54, 6613-22.
30. Fauci AS (1996). Host factors and the pathogenesis of HIV induced disease. Nature, 384, 529-34.
31. Feng Q, Dongzhi W, Qiang Z, Shengli Y (2005). Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother, 59, 64-9.
32. Figtree GA, Griffiths H, Lu YQ, et al (2000). Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol, 35, 1977-85.
33. Firuzi (2004). Hypochlorite scavenging activity of flavonoids. J Pharma Pharmacol, 56, 801-7.
34. Fung MC (1997). Effect of biochanin A on the growth and differentiation of myeloid leukemia. Life Sci, 61, 105-15.
35. Gali HV Perchellet EM, Klish DS, Johnson JM, Perchellet JP (1992). Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-0-tetradecanoyl phorbol-13-acetate in vivo. Int J Cancer, 51, 425-32.
36. Geissman TA (1963). Flavonoid compounds, tannins and related compounds, In: Florkin, M. and Stotz, E.H., (Ed), Pyrrole Pigments, Isoprenoid Compounds and Phenolic Plant Constituents. Elsevier, New York pp 265.
37. German JB, Walzem R (2000). The health benefits of wine. Annu Rev Nutr, 20, 561-93.
38. Ghadge GD, Lee JP, Bindokas VP, et al (1997). Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis, molecular mechanisms of neuronal death and protection. J Neuro Sci, 17, 8756-66.
39. Hadi SM, Asad SF, Singh S, Ahmad A (2000). Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life, 50, 1-5.
40. Hadi SM, Asfar AS, Bhat SH, et al (2007). Oxidative breakage of cellular DNA by plant polyphenols: A putative mechanism for anticancer properties. Semin Cancer Biol, 17, 370-7.
41. Hillman GG, Forman JD, Kucuk O, et al (2001). Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res, 7, 382-90.
42. Hillman GG, Wang Y, Kucuk O, et al (2004). Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther, 3, 1271-9
43. Hsu JT, Hung HC, Chen CJ, Ying C (1999). Effect of dietary phytoestrogen biochanin A on cell growth in the mammary carcinoma cell line MCF-7. J Nut BioChem, 10, 510-7.
44. Ireson CR, Orr S, Jones DJL, et al (2001). Characterization of metabolites of the chemopreventive agent curcumin in humans and rat hepatocytes and in rat plasma and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res, 61, 1058-64.
45. Joseph JA, Denisova NA, Arendash G, et al (2003). Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci, 6, 153-62.
46. Joseph JA, Shukitt-Hale B, Denisova N, et al (1999). Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci, 19, 8114-21.
47. Joyce CL, Mack SR, Anderson RA, Zaneveld LJD (1986). Effect of hyaluronidase, beta-glucuronidase and beta-N-acetyl glycosamminidase inhibitors on sperm penetration of the mouse oocytes. Biol Reprod, 35, 336-46.
48. Kawai K, Tsuno NH, Kitayama J, et al (2003). Epigallocatechin gallate the main component of tea polyphenol binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol, 112, 851-3.
49. Kazmi MH, Malik A, Hameed S, Akhtar N, Ali SN (1994). An anthraquinone derivative from Cassia italica. Phytochem, 36, 761-3.
50. Kim H, Park BS, Lee KG, et al (2005). Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem, 53, 8537-41.
51. Koh SH, Lee SM, Kim HY, et al (2006). The effect of epigallocatechin gallate on expressing diseases progression of ALS model mice. Neuro Sci Lett, 375, 103-7.
52. Krishnaveni KS, Rao JVS (2000). A new isoflavone glucoside from Pterocarpus santalinus. Asian Nat Prod Res, 2, 219.
53. Kuiper GGM, Lemmen JG, Carlsson B, et al (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor α. Endocrinology, 139, 4252-63.
54. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R (1997). Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol, 5, 193-200.
55. Lambert DJ, Hong J, Yang G, Lias J, Yand SC (2005). Inhibition of carcinogenesis by polyphenols evidence from laboratory investigations. AJCN, 81, 2845-91
56. Li CJ, Dezube BJ, Biswas DK, Ahlers CM Pardee AB (1994). Inhibition of HIV-1 Transcription. Trends Microbiol, 5, 164-9.
57. Li HL, Huang Y, Zhang CN, et al (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med, 40, 1756-75.
58. Lyn Cook BP, Stottman HL, Yan Y, Hamous GJ (1999). The effects of phytoestrogen on human pancreatic tumor cells in vitro. Cancer Lett, 142: 111-119.
59. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006). Multiple biological activities of curcumin: A short review. Life Sci, 78, 2081-87.
60. Manjunatha BK (2006). Antibacterial activity of Pterocarpus santalinus. Ind J Pharm Sci, 68, 115-6.
61. Mason TL, Wasserman BP (1987). Inactivation of red beet b-glucan synthetase by native and oxidized phenolic compounds. Phytochem, 26, 2197
62. Middleson E (1984). The flavonoids. Trends Pharmacol Sci, 5, 335-8.
63. Mills PK, Beeson WL, Philips RL, Fraser GE (1989). Cohurt study of diet, lifestyle and prostate cancer in Adventist men. Cancer, 64, 598-604
64. Morley KL, Ferguson PJ, Koropatrick J (2007). Tangeretin and nobiletin induce G1 cell arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett, 251, 168-78
65. Morris MC, Evans DA, Bienias JL, et al (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA, 287, 3230-7.
66. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK (1982). Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions, 12, 508-15.
67. Nair MP, Kandaswami C, Mahajan S, et al (2002). Grape seed extract proanthocyanidins down regulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells. Biol Res, 35, 421-1.
68. Nakahara K, Kawabata S, Ono H, et al (1993). Inhibitory effects of oolong tea polyphenols on glucosyltransferases of mutans streptococci. Appl Environ Microbiol, 59, 968-73.
69. Narayanan BA (2006). Chemopreventive agents alters global gene expression pattern: Predicting their mode of action and targets. Curr Cancer Drug Targets, 6, 711-27.
70. Papavassiliou AG (1995). Transcription factors: Structure, function and implication in malignant growth. Anticancer Res, 15, 891-4.
71. Perry G, Sayre LM, Atwood CS, et al (2002). The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs, 16, 339-52.
72. Philips M, Sabas M, Greenberg J (1993). Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol, 46, 861-864.
73. Ramassamy C (2006). Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol, 545, 51-64
74. Rike L, Samedi VG, Medrans TA, Baker HV (2002). Mechanism of the growth inhibitory effect of the isoflavonoid biochanin A on LNCaP cells and xenograft. The Prostate, 52, 201-12.
75. Rowland I, Faughnan M L, Hoey K, et al (2003). Bioavailability of phyto-oestrogens. Br J Nutr, 89, 838-52.
76. Scalbert A and Williamson G (2000). Dietary intake and bioavailability of polyphenols. J Nutr, 130, 2073-85.
77. Scarlatti F, Sala G, Rici C et al (2007). Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett, 253, 124-30.
78. Schroeter H, Spencer JP, Evans CR, William RT (2006). Flavonoids protect neuron from toxicologic low-density lipoprotein induced apoptosis. Biochem J, 388, 547-57.
79. Schultes RE: The kingdom of plants, In: WAR Thomas (Ed), Medicines from the Earth. Mc Graw Hill Book Co, New York 1978 pp 208.
80. Shang YZ, Qin BW, Cheng JJ, Miao H (2006). Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria baicalensis georgi in PC12 cells. Phytother Res, 20, 53-7.
81. Shen J, White M, Husband AJ, Hambly BD, Bao S (2006). Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. Eur J Pharmacol, 548, 123-8.
82. Shuzhong Z, Xinning Y, Robert AC, Marilyn EM (2005). Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol, 70, 627-39.
83. Singh S, Aggarwal BB (1995). Activation of transcription factor NF-kB is suppressed by curcumin (diferulolylmethane). J Biol Chem, 270, 24995-5000.
84. Stern SL, Hagerman AE, Steinberg PD, Mason PK (1996). Phlorotannin-protein interactions. J Chem Ecol, 22, 1887-90.
85. Sugiyama Y, Kawakashi S, Osawa, T (1996). Involvement of the beta-diketone moiety in the antioxidant mechanism of tetrahydrocurcumin. Biochem Pharmacol, 52, 519-25.
86. Szewczuk LM, Forti L, Stivala LA, Penning TM (2004). Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem, 279, 22727-37.
87. Toda MS, Okubo R, Ohnishi OR, Shimamura T (1989). Antibacterial and bactericidal activities of Japanese green tea. Jpn J Bacteriol, 45, 561-6.
88. Tsuchiya H, Sato M, Miyazaki T, et al (1996). Comparative study on the antibacterial activity of phytochemical flavanones against methicillin resistant Staphylococcus aureus. J Ethnopharmacol, 50, 27-34
89. Tsvetkov P, Asher G, Reiss V, et al (2005). Inhibition of NAD[P]H: Quinone oxido reductase 1 activity and induction of P53 degradation by natural phenolic compound curcumin. Proc Natl Acad Sci USA, 102, 5535-40.
90. Ullah MF (2008). Cancer therapeutics: Emerging targets and trends. Curr Cancer Ther Rev, 4, 50-6.
91. Ullah MF (2008). Cancer multidrug resistance (MDR): A major impediment to effective chemotherapy. Asian Pac J Chem Prev, 9, 1-6
92. Ulrich A, Schlessinger J (1990). Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
93. Verma R, Gupta RB, Singh K, et al (2007). Distribution of CCR5 Delta 32, CCR2-641 and SDF1-3A and plasma levels of SDF-1 in HIV-1 seronegative North Indians. J Clin Virol, 38, 198-203.
94. Vijaya K, Ananthan S, Nalini R (1995). Antibacterial effect of theaflavin, polyphenol (Camellia sinensis) and Euphorbia hirta on Shigella spp. - a cell culture study. J Ethnopharmacol, 49, 115-8.
95. Wahl H, Tan L, Griffith K, Choi M, Liu RJ (2007). Curcumin enhances Apo2L/TRAIL- induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol, 105, 104-12.
96. Walker HA, Dean TS, Sanders TA, et al (2001). The phytoestrogen genistein produces acute nitric oxide dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation, 103, 258-62.
97. Wallerath T, Deckert G, Ternes T (2002). Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation, 106, 1652-8.
98. Wang J, Ho L, Zhao Z, et al (2006). Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J, 20, 2313-20
99. Wenzel E, Somoza V (2005). Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res, 49, 472-81.
100. Wollenweber E (1988). Occurrence of flavonoid aglycones in medicinal plants. Prog Clin Biol Res, 280, 45-55.
101. Wu Baer F, Lane WS, Gaynor RB (1995). The cellular factor TRP-185 regulates RNA polymerase binding to HIV-1 TAR RNA. EMBO J, 14, 5995-6009.
102. Xia Y, Jin L, Zhang B, et al (2007). The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sci, 80, 2161-9
103. Xu Z, Chen S, Li X, Luo G, Li L, Le W (2006). Neuroprotective effects of (-)-epigallocateclun-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res, 31, 1263-9.
104. Yacoub A, Park JS, Qiao L, Dent P, Hegan MP (2001). MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in MEK K dependent fashion. Int J Radiat Biol, 77, 1067-78.
105. Yoshida D, Ikada Y, Nakayama S (1993). Quantitative analysis of copper, zinc and copper/zinc ratio in selective human brain tumors. J Neuro Oncol, 16, 109-15.
106. Zhang GH, Wang Q, Chen JJ, et al (2005). The anti-HIV I effect of scutellarin. Biochem Biophys Res Commun, 334, 812-816.